CVS Cuts Coverage of Dozens of Drugs in Exclusion ExpansionBy
Benefit manager to exclude some cancer, diabetes treatments
Company cites ‘hyperinflationary’ increases on 10 drugs
CVS Health Corp. will add 35 products to its lists of excluded drugs in 2017 and no longer cover some treatments for cancer and diabetes, in an aggressive move to favor lower-priced treatments and target what the company called “hyperinflation” of some other products.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.